amikacin has been researched along with edrophonium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hashimoto, Y; Matsukawa, S; Shima, T | 1 |
| Hashimoto, Y; Matsukawa, S; Satou, M; Shima, T | 1 |
1 review(s) available for amikacin and edrophonium
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for amikacin and edrophonium
| Article | Year |
|---|---|
[The neuromuscular blocking property of amikacin (author's transl)].
Topics: Adult; Amikacin; Animals; Calcium; Dose-Response Relationship, Drug; Drug Evaluation; Drug Synergism; Edrophonium; Humans; In Vitro Techniques; Kanamycin; Neuromuscular Blocking Agents; Rabbits; Succinylcholine; Tubocurarine | 1977 |
Neuromuscular blocking property of amikacin in man.
Topics: Adult; Amikacin; Calcium Chloride; Edrophonium; Female; Humans; Kanamycin; Male; Middle Aged; Neuromuscular Blocking Agents; Neuromuscular Junction | 1978 |